[PDF][PDF] Perioperative management of oral glucose-lowering drugs in the patient with type 2 diabetes

JC Preiser, B Provenzano… - …, 2020 - publishingimages.s3.amazonaws …
Diabetes mellitus is a group of metabolic disorders, characterized by hyperglycemia,
resulting from relative insulin deficiency, often on a background of insulin resistance (type 2 …

Performance and risks of ChatGPT used in drug information: an exploratory real-world analysis

B Morath, U Chiriac, E Jaszkowski, C Deiß… - European Journal of …, 2024 - ejhp.bmj.com
Objectives To investigate the performance and risk associated with the usage of Chat
Generative Pre-trained Transformer (ChatGPT) to answer drug-related questions. Methods A …

A pragmatic approach to inpatient diabetes management during the COVID-19 pandemic

M Korytkowski, K Antinori-Lent, A Drincic… - The Journal of …, 2020 - academic.oup.com
The pandemic of COVID-19 has presented new challenges to hospital personnel providing
care for infected patients with diabetes who represent more than 20% of critically ill patients …

Evolving evidence of diabetic ketoacidosis in patients taking sodium-glucose cotransporter 2 inhibitors

N Fleming, PS Hamblin, D Story… - The Journal of Clinical …, 2020 - academic.oup.com
Introduction Sodium glucose cotransporter 2 inhibitors (SGLT2i) have emerged as an
important class of blood glucose–lowering medications, due to cardiovascular, metabolic …

Preoperative considerations of new long-acting glucagon-like peptide-1 receptor agonists in diabetes mellitus

AH Hulst, JAW Polderman, SE Siegelaar… - British journal of …, 2021 - bjanaesthesia.org
Study design should focus around meeting as many of the Bradford Hill criteria possible,
and the power and P-value chosen to achieve the highest possible study PPV and NPV …

[HTML][HTML] Diabetic perioperative management

P Dogra, C Anastasopoulou, I Jialal - StatPearls [Internet], 2024 - ncbi.nlm.nih.gov
Diabetic Perioperative Management - StatPearls - NCBI Bookshelf US flag An official website
of the United States government Here's how you know NIH NLM Logo Access keys NCBI …

Practical Guidance for the Use of SGLT2 Inhibitors in Heart Failure

I Cavallari, SP Crispino, A Segreti, GP Ussia… - American Journal of …, 2023 - Springer
Despite continuous advances in both diagnosis and management, heart failure (HF) still
represents a major worldwide health issue. Recently, sodium-glucose co-transporter 2 …

Perioperative euglycemic diabetic ketoacidosis following use of SGLT-2 inhibitors after cardiac surgery

JPJ Pontes, CS de Melo… - Journal of clinical …, 2021 - pubmed.ncbi.nlm.nih.gov
Perioperative euglycemic diabetic ketoacidosis following use of SGLT-2 inhibitors after cardiac
surgery Perioperative euglycemic diabetic ketoacidosis following use of SGLT-2 inhibitors after …

[HTML][HTML] Short-term clinical and biochemical responses following treatment with dapagliflozin or ertugliflozin in horses with hyperinsulinemia: a retrospective case …

T Sundra, E Knowles, D Rendle, E Kelty… - Domestic animal …, 2025 - Elsevier
The metabolic and lipid profiles of horses treated with sodium-glucose cotransporter 2
inhibitors are not well understood. This retrospective study evaluated blood parameters in …

SGLT-2 inhibitors: proliferating indications and perioperative pitfalls

J Madhok, MW Vanneman - Journal of Cardiothoracic and Vascular …, 2022 - jcvaonline.com
SODIUM-GLUCOSE COTRANSPORTER-2 (SGLT-2) inhibitors are a relatively new
generation of oral glucose-lowering agents in the armamentarium of drugs used in the …